SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
RPT Realty (RPT-PD) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 31/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — RPT-PD
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio8.19
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.36
Book Value / Share$0.00
Revenue / Share$6.97
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.66 |
$260.93M |
$59.66M |
22.9% |
| 2017 |
$0.78 |
$265.08M |
$69.06M |
26.1% |
| 2018 |
$0.22 |
$260.62M |
$17.62M |
6.8% |
| 2019 |
$1.04 |
$234.09M |
$91.51M |
39.1% |
| 2020 |
$-0.13 |
$191.71M |
$-10.47M |
-5.5% |
| 2021 |
$0.75 |
$213.49M |
$68.64M |
32.2% |
| 2022 |
$-0.33 |
$217.66M |
$-15.01M |
-6.9% |
| 2023 |
$-2.01 |
$-16.86M |
$-47.07M |
- |
| 2024 |
$-2.29 |
$47.22M |
$-91.84M |
-194.5% |
| 2025 |
$-0.36 |
$52.8M |
$1.47M |
2.8% |
